The primary objective of the ongoing trial is to determine whether ambrisentan can prevent the progression to respiratory failure and reduce the need for mechanical ventilation, among others
The state-of-the-art facility provides a pathway from development to large-scale biologics production
Lonza, a global manufacturing partner to the pharma, biotech and nutrition industries, has announced it will invest in additional drug product manufacturing capabilities in Switzerland
The company said the safety profile remained consistent with earlier studies and was considered manageable
The new facility aims to accelerate formulation science and application-led research across pharma, biopharma, nutraceuticals, personal care, and home care segments
The safety profile was described as manageable, though not without notable toxicities
SERB has a substantial European commercial presence and a successful track record in critical care and rare disease commercialization
Union Health Minister highlights India’s progress in universal health coverage, digital health, AI strategy and global vaccine cooperation during plenary session in Geneva
Shilpa will deliver end-to-end services including CMC development, process scale-up, GMP clinical supply, and commercial manufacturing support
Expands manufacturing push & locks in major growth deals
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
